What is Regeneron Pharmaceuticals's total revenue?

Regeneron Pharmaceuticals (REGN) reported total revenue of $3.61B in Q1 2026.

How has Regeneron Pharmaceuticals's total revenue changed year-over-year?

Regeneron Pharmaceuticals's total revenue increased by 19.0% year-over-year, from $3.03B to $3.61B.

What is the long-term trend for Regeneron Pharmaceuticals's total revenue?

Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's total revenue has grown at a -2.8% compound annual growth rate (CAGR), from $16.07B to $14.34B.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Regeneron Pharmaceuticals REGN Total Revenue

Total Revenue at other companies

Merck & Co.MRK

$16.29B+4.9%

AmgenAMGN

$8.62B+5.8%

Celldex TherapeuticsCLDX

$15K-97.8%

Nektar TherapeuticsNKTR

$10.86M+3.8%

GlaukosGKOS

$150.57M+41.2%

EyePoint, Inc. EYPT

$696K-97.2%

Segments

By product

See full

Reimbursement For Manufacturing Of Commercial Supplies$165M—

Reimbursement Of Commercialization Related Expenses$159.2M—

(Regeneron's obligation for its share of Sanofi R&D expenses)/reimbursements of R&D expenses, net-$15.5M—

Other financials

Income statement

See full

Operating income$642.9M+8.7%

Net income$727.2M-10.1%

EPS (diluted)$6.75-7.2%

Balance sheet

See full

Cash & equivalents$3.0B-4.0%

Total debt$2.7B+0.1%

Total equity$31.4B+6.9%

Total assets$40.9B+8.9%

Cash flow

See full

Operating cash flow$1.1B+3.2%

CapEx$230.6M+0.6%

Free cash flow$848.3M+4.0%

Valuation

See full

Market cap$65.01B+18.1%

Enterprise value$64.75B+18.5%

P/E14.7×+2.5×

P/S4.4×+0.5×

Profitability

See full

Gross margin93.9%—

Operating margin24.3%-2.9pp

Net margin29.6%-2.3pp

FCF margin27.6%+5.5pp

Returns & leverage

See full

Return on equity14.5%-1.4pp

Debt / equity0.1×0.0×

Current ratio3.6×-1.4×

Where this comes from

Reported directly by Regeneron Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regeneron Pharmaceuticals's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regeneron Pharmaceuticals's total revenue?: Regeneron Pharmaceuticals (REGN) reported total revenue of $3.61B in Q1 2026.
How has Regeneron Pharmaceuticals's total revenue changed year-over-year?: Regeneron Pharmaceuticals's total revenue increased by 19.0% year-over-year, from $3.03B to $3.61B.
What is the long-term trend for Regeneron Pharmaceuticals's total revenue?: Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's total revenue has grown at a -2.8% compound annual growth rate (CAGR), from $16.07B to $14.34B.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.